Supplementary Legal Opinion (II) from Junzejun Law Offices on the Issuance of Shares for Asset Acquisition and Related Transactions by Meinian Onehealth Healthcare Holdings Co., Ltd.

Supplementary Legal Opinion (II)

Junzejun Law Offices
24th Floor, Taikang Group Building, Building 1, 16 Jinghui Street, Chaoyang District, Beijing 100026, China
Tel: 861066523388
Fax: 861066523399
Https://www.junzejun.com

Table of Contents

1. Definitions ........................................................................................................................................ 2
2. Supplementary Verification of Related Matters ........................................................................... 7
   1. Transaction Plan .................................................................................................................... 7
   2. Qualification of Related Parties ............................................................................................ 7
   3. Approvals and Authorizations for the Transaction ................................................................ 8
   4. Related Agreements for the Transaction .............................................................................. 9
   5. Target Assets of the Transaction .......................................................................................... 10
   6. Related Transactions and Competition Issues ..................................................................... 64
   7. Handling of Debts and Credits Related to the Transaction .................................................. 65
   8. Information Disclosure Related to the Transaction ............................................................... 65
   9. Substantive Conditions of the Transaction .......................................................................... 67
   10. Verification of Securities Transactions by Related Parties .................................................. 67
   11. Securities Service Institutions Involved in the Transaction and Their Qualifications ........ 67
   12. Other Issues to be Explained .............................................................................................. 68
   13. Conclusion ............................................................................................................................ 74
3. Supplementary Updates on Responses to the "Review Inquiry Letter" .................................... 76
   1. Inquiry Question 1: Necessity of the Transaction ................................................................ 76
   2. Inquiry Question 2: Counterparty of the Transaction ............................................................ 87
   3. Inquiry Question 3: Compliance of Target Assets' Operations ............................................. 115
   4. Inquiry Question 4: Performance Commitments .................................................................. 135